A Cell-Based Screen Reveals that the Albendazole Metabolite, Albendazole Sulfone, Targets Wolbachia

PLoS Pathogens

Volumn 8, Issue 9, 2012, Pages

  Serbus, Laura R ^a   Landmann, Frederic ^a   Bray, Walter M ^a   White, Pamela M ^a   Ruybal, Jordan ^a   Lokey, R Scott ^a   Debec, Alain ^b   Sullivan, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; DNA; DOXYCYCLINE; FLUORESCENT DYE; FTSZ PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ANTIBODY TITER; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DROSOPHILA; DRUG TARGETING; FOLLOW UP; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; METABOLITE; MICROTUBULE; MICROTUBULE ORGANIZING CENTER; NEMATODE; NONHUMAN; PHENOTYPE; STAINING; WOLBACHIA;

ALBENDAZOLE; ANIMALS; BRUGIA MALAYI; CELL LINE; DROSOPHILA MELANOGASTER; FILARIASIS; MICROBIAL SENSITIVITY TESTS; MICROTUBULES; SYMBIOSIS; WOLBACHIA;

BRUGIA MALAYI; DROSOPHILA MELANOGASTER; NEMATODA; WOLBACHIA;

EID: 84866910326     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002922     Document Type: Article

References (121)

1. Hilgenboecker K, Hammerstein P, Schlattmann P, Telschow A, Werren JH, (2008) How many species are infected with Wolbachia?- a statistical analysis of current data. FEMS Microbiol Lett 281: 215-20.
2. Serbus LR, Casper-Lindley C, Landmann F, Sullivan W, (2008) The Genetics and Cell Biology of Wolbachia-Host Interactions. Annu Rev Genet 42: 683-707.
3. Werren JH, Baldo L, Clark ME, (2008) Wolbachia: master manipulators of invertebrate biology. Nat Rev Microbiol 6: 741-751.
4. Harris HL, Braig HR, (2003) Sperm chromatin remodelling and Wolbachia-induced cytoplasmic incompatibility in Drosophila. Biochem Cell Biol 81: 229-240.
5. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S, (2011) Filariasis in Africa-treatment challenges and prospects. Clin Microbiol Infect 17: 977-985.
6. Taylor MJ, Hoerauf A, Bockarie M, (2010) Lymphatic filariasis and onchocerciasis. Lancet 376: 1175-1185.
7. WHO (2010) World Health Organization Global Programme to Eliminate Lymphatic Filariasis, Progress Report 2000-2009 and Strategic Plan 2010-2020. Geneva: World Health Organization. 78 p.
8. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, et al. (2009) Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am J Trop Med Hyg 80: 956-963.
9. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, et al. (2006) Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2: e92.
10. Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, et al. (2009) Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 284: 22364-22378.
11. Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, et al. (2004) The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol 173: 437-445.
12. Brattig NW, Buttner DW, Hoerauf A, (2001) Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect 3: 439-446.
13. Saint Andre A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, et al. (2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295: 1892-1895.
14. Taylor MJ, Cross HF, Bilo K, (2000) Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med 191: 1429-1436.
15. Hise AG, Daehnel K, Gillette-Ferguson I, Cho E, McGarry HF, et al. (2007) Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol 178: 1068-1076.
16. Turner JD, Langley RS, Johnston KL, Egerton G, Wanji S, et al. (2006) Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88/TLR2-dependent manner. J Immunol 177: 1240-1249.
17. Pfarr KM, Debrah AY, Specht S, Hoerauf A, (2009) Filariasis and lymphoedema. Parasite Immunol 31: 664-672.
18. Korten S, Badusche M, Buttner DW, Hoerauf A, Brattig N, et al. (2008) Natural death of adult Onchocerca volvulus and filaricidal effects of doxycycline induce local FOXP3+/CD4+ regulatory T cells and granzyme expression. Microbes Infect 10: 313-324.
19. Fernando SD, Rodrigo C, Rajapakse S, (2011) Current evidence on the use of antifilarial agents in the management of bancroftian filariasis. J Trop Med 2011: 175941.
20. McGarry HF, Plant LD, Taylor MJ, (2005) Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. Filaria J 4: 4.
21. Omura S, Crump A, (2004) The life and times of ivermectin- a success story. Nat Rev Microbiol 2: 984-989.
22. Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG, (2010) Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci U S A 107: 20120-20125.
23. Horton J, (2009) The development of albendazole for lymphatic filariasis. Ann Trop Med Parasitol 103 (Suppl 1):: S33-40.
24. Marriner SE, Morris DL, Dickson B, Bogan JA, (1986) Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30: 705-708.
25. Mirfazaelian A, Dadashzadeh S, Rouini MR, (2002) Effect of gender in the disposition of albendazole metabolites in humans. Eur J Clin Pharmacol 58: 403-408.
26. Gottschall DW, Theodorides VJ, Wang R, (1990) The metabolism of benzimidazole anthelmintics. Parasitol Today 6: 115-124.
27. Gaur RL, Dixit S, Sahoo MK, Khanna M, Singh S, et al. (2007) Anti-filarial activity of novel formulations of albendazole against experimental brugian filariasis. Parasitology 134: 537-544.
28. Bockarie MJ, Tavul L, Ibam I, Kastens W, Hazlett F, et al. (2007) Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg 76: 62-66.
29. El Setouhy M, Ramzy RM, Ahmed ES, Kandil AM, Hussain O, et al. (2004) A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg 70: 191-196.
30. Hussein O, El Setouhy M, Ahmed ES, Kandil AM, Ramzy RM, et al. (2004) Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis. Am J Trop Med Hyg 71: 471-477.
31. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, et al. (1998) Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 92: 94-97.
32. Ismail MM, Jayakody RL, Weil GJ, Fernando D, De Silva MS, et al. (2001) Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 95: 332-335.
33. Bosshardt SC, McCall JW, Coleman SU, Jones KL, Petit TA, et al. (1993) Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unguiculatus). J Parasitol 79: 775-777.
34. Bandi C, McCall JW, Genchi C, Corona S, Venco L, et al. (1999) Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol 29: 357-364.
35. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, et al. (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355: 1242-1243.
36. Hoerauf A, (2000) Targeting of wolbachia endobacteria in litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin. Trop Med Int Health 5: 275-279.
37. Landmann F, Voronin D, Sullivan W, Taylor MJ, (2011) Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes. PLoS Pathog 7: e1002351.
38. Fenn K, Blaxter M, (2004) Are filarial nematode Wolbachia obligate mutualist symbionts? Trends Ecol Evol 19: 163-166.
39. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, et al. (2007) Draft genome of the filarial nematode parasite Brugia malayi. Science 317: 1756-1760.
40. Foster J, Ganatra M, Kamal I, Ware J, Makarova K, et al. (2005) The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol 3: e121.
41. Sironi M, Bandi C, Sacchi L, Di Sacco B, Damiani G, et al. (1995) Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm. Mol Biochem Parasitol 74: 223-227.
42. Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, et al. (2003) Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 5: 261-273.
43. Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW, (2001) Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357: 1415-1416.
44. Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, et al. (2009) Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res 104: 437-447.
45. Hoerauf A, Specht S, Buttner M, Pfarr K, Mand S, et al. (2008) Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol 197: 295-311.
46. Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, et al. (2005) Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 365: 2116-2121.
47. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, et al. (2007) Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health 12: 1433-1441.
48. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP, (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2 (Suppl 1):: S4.
49. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, et al. (2010) Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis 4: e660.
50. Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, et al. (2006) A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis 42: 1081-1089.
51. Szollosi A, Debec A, (1980) Presence of Rickettsias in Haploid Drosophila melanogaster Cell Lines. Extrait Biologie Cellulaire 38: 129-134.
52. Karpova N, Bobinnec Y, Fouix S, Huitorel P, Debec A, (2006) Jupiter, a new Drosophila protein associated with microtubules. Cell Motil Cytoskeleton 63: 301-312.
53. Kose H, Karr TL, (1995) Organization of Wolbachia pipientis in the Drosophila fertilized egg and embryo revealed by an anti-Wolbachia monoclonal antibody. Mech Dev 51: 275-288.
54. Ferree PM, Frydman HM, Li JM, Cao J, Wieschaus E, et al. (2005) Wolbachia utilizes host microtubules and Dynein for anterior localization in the Drosophila oocyte. PLoS Pathog 1: e14.
55. Serbus LR, Sullivan W, (2007) A Cellular Basis for Wolbachia Recruitment to the Host Germline. PLoS Pathog 3: e190.
56. Albertson R, Casper-Lindley C, Cao J, Tram U, Sullivan W, (2009) Symmetric and asymmetric mitotic segregation patterns influence Wolbachia distribution in host somatic tissue. J Cell Sci 122: 4570-4583.
57. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, et al. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286: 971-974.
58. Perrimon N, Friedman A, Mathey-Prevot B, Eggert US, (2007) Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens. Drug Discov Today 12: 28-33.
59. Jaiswal R, Beuria TK, Mohan R, Mahajan SK, Panda D, (2007) Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. Biochemistry 46: 4211-4220.
60. Kapitzky L, Beltrao P, Berens TJ, Gassner N, Zhou C, et al. (2010) Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action. Mol Syst Biol 6: 451.
61. Tischer M, Pradel G, Ohlsen K, Holzgrabe U, (2012) Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions? ChemMedChem 7: 22-31.
62. Muggia FM, Green MD, (1991) New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol 11: 43-64.
63. Skladanowski A, Konopa J, (1994) Interstrand DNA crosslinking induced by anthracyclines in tumour cells. Biochem Pharmacol 47: 2269-2278.
64. Pommier Y, Leo E, Zhang H, Marchand C, (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17: 421-433.
65. Tomasz M, Palom Y, (1997) The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Ther 76: 73-87.
66. Bell AJ, McBride SM, Dockendorff TC, (2009) Flies as the ointment: Drosophila modeling to enhance drug discovery. Fly (Austin) 3: 39-49.
67. Serbus L, Ferreccio A, Zhukova M, McMorris C, Kiseleva E, et al. (2011) A feedback loop between Wolbachia and the Drosophila gurken mRNP complex influences Wolbachia titer. J Cell Sci 124: 4299-4308.
68. King RC (1970) Ovarian development in Drosophila melanogaster. New York: Academic Press. 227 p.
69. Kimble J, Crittenden SL (2005) Germline proliferation and its control. In: Community TCeR, editor. WormBook: doi/10.1895/wormbook.1.13.1, http://www.wormbook.org.
70. Lacey E, (1988) The role of the cytoskeletal protein tubulin in the mode of action and mechanism of drug resistance to benzimidazole carbamates. Int J Parasitol 18: 885-936.
71. Borgers M, De Nollin S, (1975) Ultrastructural changes in Ascaris suum intestine after mebendazole treatment in vivo. J Parasitol 61: 110-122.
72. Lubega GW, Prichard RK, (1991) Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp Parasitol 73: 203-213.
73. Schaffner-Barbero C, Martin-Fontecha M, Chacon P, Andreu JM, (2011) Targeting the assembly of bacterial cell division protein FtsZ with small molecules. ACS Chem Biol 7: 269-277.
74. Robinson MW, McFerran N, Trudgett A, Hoey L, Fairweather I, (2004) A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. J Mol Graph Model 23: 275-284.
75. Veneti Z, Clark ME, Karr TL, Savakis C, Bourtzis K, (2004) Heads or tails: host-parasite interactions in the Drosophila-Wolbachia system. Appl Environ Microbiol 70: 5366-5372.
76. Serbus LR, Cha BJ, Theurkauf WE, Saxton WM, (2005) Dynein and the actin cytoskeleton control kinesin-driven cytoplasmic streaming in Drosophila oocytes. Development 132: 3743-3752.
77. Theurkauf WE, Smiley S, Wong ML, Alberts BM, (1992) Reorganization of the cytoskeleton during Drosophila oogenesis: implications for axis specification and intercellular transport. Development 115: 923-936.
78. Landmann F, Bain O, Martin C, Uni S, Taylor M, et al. (2012) Both asymmetric mitotic segregation and cell-to-cell invasion are required for stable germline transmission of Wolbachia in filarial nematodes. Biology Open In press.
79. Fenollar F, La Scola B, Inokuma H, Dumler JS, Taylor MJ, et al. (2003) Culture and phenotypic characterization of a Wolbachia pipientis isolate. J Clin Microbiol 41: 5434-5441.
80. Dobson SL, Marsland EJ, Veneti Z, Bourtzis K, O'Neill SL, (2002) Characterization of Wolbachia host cell range via the in vitro establishment of infections. Appl Environ Microbiol 68: 656-660.
81. Frentiu FD, Robinson J, Young PR, McGraw EA, O'Neill SL, (2010) Wolbachia-mediated resistance to dengue virus infection and death at the cellular level. PLoS One 5: e13398.
82. Voronin DA, Bochernikov AM, Baricheva EM, Zakharov IK, Kiseleva EV, (2009) [Influence of Drosophila melanogaster genotype on biological effects of endocymbiont Wolbachia (stamm wMelPop)]. Tsitologiia 51: 335-345.
83. Venard CM, Crain PR, Dobson SL, (2011) SYTO11 staining vs FISH staining: a comparison of two methods to stain Wolbachia pipientis in cell cultures. Lett Appl Microbiol 52: 168-176.
84. O'Neill SL, Pettigrew MM, Sinkins SP, Braig HR, Andreadis TG, et al. (1997) In vitro cultivation of Wolbachia pipientis in an Aedes albopictus cell line. Insect Mol Biol 6: 33-39.
85. Casper-Lindley C, Kimura S, Saxton DS, Essaw Y, Simpson I, et al. (2011) Rapid fluorescence-based screening for Wolbachia endosymbionts in Drosophila germ line and somatic tissues. Appl Environ Microbiol 77: 4788-4794.
86. Li Z, Garner AL, Gloeckner C, Janda KD, Carlow CK, (2011) Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy. PLoS Negl Trop Dis 5: e1411.
87. Katz M, (1977) Anthelmintics. Drugs 13: 124-136.
88. Cline BL, (1982) Current drug regimens for the treatment of intestinal helminth infections. Med Clin North Am 66: 721-742.
89. Bordenstein SR, Fitch DH, Werren JH, (2003) Absence of Wolbachia in Nonfilariid Nematodes. J Nematol 35: 266-270.
90. Lin M, Zhang C, Gibson K, Rikihisa Y, (2009) Analysis of complete genome sequence of Neorickettsia risticii: causative agent of Potomac horse fever. Nucleic Acids Res 37: 6076-6091.
91. WHO (2000) Lymphatic Filariasis, Fact Sheet No. 102. World Health Organization.
92. Barrowman MM, Marriner SE, Bogan JA, (1984) The binding and subsequent inhibition of tubulin polymerization in Ascaris suum (in vitro) by benzimidazole anthelmintics. Biochem Pharmacol 33: 3037-3040.
93. Ridoux O, Drancourt M, (1998) In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites. Antimicrob Agents Chemother 42: 3301-3303.
94. Ramsden AE, Holden DW, Mota LJ, (2007) Membrane dynamics and spatial distribution of Salmonella-containing vacuoles. Trends Microbiol 15: 516-524.
95. Steele-Mortimer O, (2008) The Salmonella-containing vacuole: moving with the times. Curr Opin Microbiol 11: 38-45.
96. Rajashekar R, Hensel M, (2011) Dynamic modification of microtubule-dependent transport by effector proteins of intracellular Salmonella enterica. Eur J Cell Biol 90: 897-902.
97. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER, (1999) The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1: 119-130.
98. Clausen JD, Christiansen G, Holst HU, Birkelund S, (1997) Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection. Mol Microbiol 25: 441-449.
99. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA, (1996) Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. Embo J 15: 964-977.
100. Grieshaber SS, Grieshaber NA, Hackstadt T, (2003) Chlamydia trachomatis uses host cell dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process. J Cell Sci 116: 3793-3802.
101. Capmany A, Damiani MT, (2010) Chlamydia trachomatis intercepts Golgi-derived sphingolipids through a Rab14-mediated transport required for bacterial development and replication. PLoS One 5: e14084.
102. Erickson HP, (1997) FtsZ, a tubulin homologue in prokaryote cell division. Trends Cell Biol 7: 362-367.
103. Margolin W, (2005) FtsZ and the division of prokaryotic cells and organelles. Nat Rev Mol Cell Biol 6: 862-871.
104. Slayden RA, Knudson DL, Belisle JT, (2006) Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology 152: 1789-1797.
105. White EL, Suling WJ, Ross LJ, Seitz LE, Reynolds RC, (2002) 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J Antimicrob Chemother 50: 111-114.
106. Reynolds RC, Srivastava S, Ross LJ, Suling WJ, White EL, (2004) A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ. Bioorg Med Chem Lett 14: 3161-3164.
107. Margalit DN, Romberg L, Mets RB, Hebert AM, Mitchison TJ, et al. (2004) Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality. Proc Natl Acad Sci U S A 101: 11821-11826.
108. Sarcina M, Mullineaux CW, (2000) Effects of tubulin assembly inhibitors on cell division in prokaryotes in vivo. FEMS Microbiol Lett 191: 25-29.
109. Susanto C (2010) Design and Synthesis of Novel Benzimidazole Library for the Discovery and Development of the Next Generation Antibacterial Agents. Stony Brook: Stony Brook University. 72 p.
110. Haydon DJ, Stokes NR, Ure R, Galbraith G, Bennett JM, et al. (2008) An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science 321: 1673-1675.
111. Nova E, Montecinos F, Brunet JE, Lagos R, Monasterio O, (2007) 4′,6-Diamidino-2-phenylindole (DAPI) induces bundling of Escherichia coli FtsZ polymers inhibiting the GTPase activity. Arch Biochem Biophys 465: 315-319.
112. Adams DW, Wu LJ, Czaplewski LG, Errington J, (2011) Multiple effects of benzamide antibiotics on FtsZ function. Mol Microbiol 80: 68-84.
113. Andreu JM, Schaffner-Barbero C, Huecas S, Alonso D, Lopez-Rodriguez ML, et al. (2010) The antibacterial cell division inhibitor PC190723 is an FtsZ polymer-stabilizing agent that induces filament assembly and condensation. J Biol Chem 285: 14239-14246.
114. Kumar K, Awasthi D, Lee SY, Zanardi I, Ruzsicska B, et al. (2010) Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents. J Med Chem 54: 374-381.
115. Czaplewski LG, Collins I, Boyd EA, Brown D, East SP, et al. (2009) Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Bioorg Med Chem Lett 19: 524-527.
116. Bi E, Lutkenhaus J, (1993) Cell division inhibitors SulA and MinCD prevent formation of the FtsZ ring. J Bacteriol 175: 1118-1125.
117. Cordell SC, Robinson EJ, Lowe J, (2003) Crystal structure of the SOS cell division inhibitor SulA and in complex with FtsZ. Proc Natl Acad Sci U S A 100: 7889-7894.
118. Hoerauf A, Nissen-Pahle K, Schmetz C, Henkle-Duhrsen K, Blaxter ML, et al. (1999) Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 103: 11-18.
119. Genchi C, Sacchi L, Bandi C, Venco L, (1998) Preliminary results on the effect of tetracycline on the embryogenesis and symbiotic bacteria (Wolbachia) of Dirofilaria immitis. An update and discussion. Parassitologia 40: 247-249.
120. Zhang JH, Chung TD, Oldenburg KR, (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73.
121. Landmann F, Foster JM, Slatko B, Sullivan W, (2010) Asymmetric Wolbachia segregation during early Brugia malayi embryogenesis determines its distribution in adult host tissues. PLoS Negl Trop Dis 4: e758.